THE T-CELL RESPONSE TO ANTIGEN
THE T-CELL RESPONSE TO ANTIGEN
批准号:
6196857
负责人:
HARVEY CANTOR
金额:
$26.61万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2000
资助国家:
美国
项目状态:
已结题
起止时间:
2000-04-01 至 2005-03-31
关键词:
T cell receptor autoimmune disorder autoimmunity biological signal transduction cellular immunity cytotoxic T lymphocyte gene expression gene targeting genetically modified animals helper T lymphocyte interferon gamma interleukin 10 interleukin 12 laboratory mouse leukocyte activation /transformation macrophage microbiology natural killer cells protein structure function transcription factor transposon /insertion element virus infection mechanism
中文摘要
一个可能在这些反应中起早期和关键作用的基因产物是我们克隆的称为Eta-1(早期t淋巴细胞激活-1)的t细胞细胞因子。该基因具有以下特点:Eta-1基因是TCR连接后表达的最丰富的新转录mRNA物种,编码一种分泌的磷酸化蛋白,导致巨噬细胞在体外和体内活化和趋化迁移,可能是对几种细胞内病原体产生遗传抗性的原因。Eta-1的过表达可能在MRL/lpr小鼠自身免疫性疾病的发病机制中起核心作用。我们最近的研究表明,继发于靶向基因突变的Eta-1基因表达不足的小鼠在病毒感染后无法产生DTH反应和相关的th1驱动的自身免疫。这些有缺陷的免疫反应与体内IL-12产生减少和IL-10产生过多有关。这种体内反应可能反映了Eta-1的N端与其整合素受体alphavbeta3之间的相互作用,导致IL-12分泌和IL-10表达的抑制。这些发现确定了Eta-1是一个关键的、非冗余的细胞因子,它启动Th1炎症反应,并提供了一种机制,通过这种机制,t细胞对外来抗原的识别可能控制抗菌炎症反应的发展。我们建议通过结构/功能研究来确定Eta-1与巨噬细胞受体(SA1)之间的分子相互作用以及随后调节IL-12/IL-10基因表达的细胞内事件(SA2)。我们还建议研究确定Eta-1在Th1/DTH向常规抗原(SA3)发展中的作用,以及它对微生物病原体和器官特异性自身免疫性疾病(SA4)的Th1依赖性应答的贡献。
英文摘要
A gene product that may play an early and critical role in these responses is a T-cell cytokine we have cloned termed Eta-1 (for Early T-lymphocyte activation-1). This gene has the following features: the Eta-1 gene is the most abundant newly-transcribed mRNA species expressed after TCR ligation, encoding a secreted phosphoprotein that leads to macrophage activation and chemotactic migration in vitro and in vivo and may account for genetic resistance to several intracellular pathogens. Overexpression of Eta-1 may play a central role in the pathogenesis of autoimmune disease in MRL/lpr mice. Our recent studies indicate that mice deficient in Eta-1 gene expression secondary to targeted gene mutation fail to develop DTH responses and associated Th1-driven autoimmunity after viral infection. These defective immune responses are associated with diminished in vivo production of IL-12 and excessive production of IL-10. This in vivo response may reflect an interaction between the N- terminal portion of Eta-1 and its integrin receptor, alphavbeta3, leading to IL-12 secretion and inhibition of IL-10 expression. These findings identify Eta-1 as a critical and non-redundant cytokine that initiates Th1 inflammatory responses and provide a mechanism by which T-cell recognition of foreign antigens may govern the development of antimicrobial inflammatory responses. We propose structure/function studies to define the molecular interaction between Eta-1 and macrophage receptor(s) (SA1) and subsequent intracellular events (SA2) that regulate IL-12/IL-10 gene expression. We also propose studies to define the role of Eta-1 in Th1/DTH development to conventional antigen (SA3) and its contribution to Th1-dependent responses to microbiological pathogens and organ-specific autoimmune disease (SA4).
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Immunologic mechanisms that prevent autoimmunity
-
批准号:10265652
-
项目类别:
-
资助金额:$40.78万
-
财政年份:2020
-
负责人:HARVEY CANTOR
-
依托单位:
THE T-CELL RESPONSE TO ANTIGEN
-
批准号:6374616
-
项目类别:
-
资助金额:$27.37万
-
财政年份:2000
-
负责人:HARVEY CANTOR
-
依托单位:
Regulation of the follicular T-cell response to autoimmunity
-
批准号:10066305
-
项目类别:
-
资助金额:$42.95万
-
财政年份:2000
-
负责人:HARVEY CANTOR
-
依托单位:
THE T-CELL RESPONSE TO ANTIGEN
-
批准号:6511531
-
项目类别:
-
资助金额:$28.12万
-
财政年份:2000
-
负责人:HARVEY CANTOR
-
依托单位:
Innate cytokine responses that regulate autoimmunity
-
批准号:7650695
-
项目类别:
-
资助金额:$36.55万
-
财政年份:2000
-
负责人:HARVEY CANTOR
-
依托单位:
THE T-CELL RESPONSE TO ANTIGEN
-
批准号:6632442
-
项目类别:
-
资助金额:$28.93万
-
财政年份:2000
-
负责人:HARVEY CANTOR
-
依托单位:
Regulation of the follicular T-cell response to autoimmunity
-
批准号:9199455
-
项目类别:
-
资助金额:$43.33万
-
财政年份:2000
-
负责人:HARVEY CANTOR
-
依托单位:
Innate cytokine responses that regulate autoimmunity
-
批准号:7768461
-
项目类别:
-
资助金额:$36.13万
-
财政年份:2000
-
负责人:HARVEY CANTOR
-
依托单位:
Innate cytokine responses that regulate autoimmunity
-
批准号:8212189
-
项目类别:
-
资助金额:$35.65万
-
财政年份:2000
-
负责人:HARVEY CANTOR
-
依托单位:
THE T-CELL RESPONSE TO ANTIGEN
-
批准号:6721340
-
项目类别:
-
资助金额:$29.79万
-
财政年份:2000
-
负责人:HARVEY CANTOR
-
依托单位:
Innate cytokine responses that regulate autoimmunity
-
批准号:8016571
-
项目类别:
-
资助金额:$35.71万
-
财政年份:2000
-
负责人:HARVEY CANTOR
-
依托单位:
T CELL RECEPTOR COUPLED SIGNALING AND APOPTOSIS
-
批准号:6099898
-
项目类别:
-
资助金额:$0.0万
-
财政年份:1998
-
负责人:HARVEY CANTOR
-
依托单位:
T CELL RECEPTOR COUPLED SIGNALING AND APOPTOSIS
-
批准号:6235317
-
项目类别:
-
资助金额:$20.03万
-
财政年份:1997
-
负责人:HARVEY CANTOR
-
依托单位:
POSTDOCTORAL RESEARCH TRAINING IN CANCER IMMUNOLOGY
-
批准号:7123850
-
项目类别:
-
资助金额:$24.18万
-
财政年份:1997
-
负责人:HARVEY CANTOR
-
依托单位:
POSTDOCTORAL RESEARCH TRAINING IN CANCER IMMUNOLOGY
-
批准号:2895490
-
项目类别:
-
资助金额:$14.97万
-
财政年份:1997
-
负责人:HARVEY CANTOR
-
依托单位:
POSTDOCTORAL RESEARCH TRAINING IN CANCER IMMUNOLOGY
-
批准号:6771907
-
项目类别:
-
资助金额:$26.81万
-
财政年份:1997
-
负责人:HARVEY CANTOR
-
依托单位:
Postdoctoral Training Program in Cancer Immunology
-
批准号:7504248
-
项目类别:
-
资助金额:$19.63万
-
财政年份:1997
-
负责人:HARVEY CANTOR
-
依托单位:
POSTDOCTORAL RESEARCH TRAINING IN CANCER IMMUNOLOGY
-
批准号:6376232
-
项目类别:
-
资助金额:$21.02万
-
财政年份:1997
-
负责人:HARVEY CANTOR
-
依托单位:
Postdoctoral Training Program in Cancer Immunology
-
批准号:8288582
-
项目类别:
-
资助金额:$20.19万
-
财政年份:1997
-
负责人:HARVEY CANTOR
-
依托单位:
Postdoctoral Training Program in Cancer Immunology
-
批准号:8103238
-
项目类别:
-
资助金额:$28.89万
-
财政年份:1997
-
负责人:HARVEY CANTOR
-
依托单位:
海外基金